| scholarly article | Q13442814 |
| P50 | author | Amy C Justice | Q42395670 |
| Kristina Crothers | Q42768813 | ||
| Matthew B. Goetz | Q44007949 | ||
| Steven G Deeks | Q57425986 | ||
| Lewis Kuller | Q88077314 | ||
| P2093 | author name string | Jason Baker | |
| Adam Gordon | |||
| Russell Tracy | |||
| Kaku A Armah | |||
| David Rimland | |||
| Kendall J Bryant | |||
| Adeel A Butt | |||
| Krisann K Oursler | |||
| David A Leaf | |||
| Mariana Gerschenson | |||
| Charles Rinaldo | |||
| Cynthia Gibert | |||
| Sheldon Brown | |||
| Maria Rodriguez-Barradas | |||
| Matthew Freiberg | |||
| Kevin Kraemer | |||
| Kathleen McGinnis | |||
| Steve Crystal | |||
| P2860 | cites work | CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 |
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
| Inflammatory and coagulation biomarkers and mortality in patients with HIV infection | Q28473903 | ||
| K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 | ||
| Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice | Q29615055 | ||
| C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus | Q29619398 | ||
| CD4+ count-guided interruption of antiretroviral treatment | Q29619489 | ||
| Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events | Q32025738 | ||
| High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection | Q33556997 | ||
| Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. | Q33606548 | ||
| The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. | Q33807791 | ||
| Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection | Q33857515 | ||
| Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. | Q33898507 | ||
| Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection | Q33907642 | ||
| Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy | Q33924628 | ||
| Quality Enhancement Research Initiative in ischemic heart disease: a quality initiative from the Department of Veterans Affairs. QUERI IHD Executive Committee | Q33937365 | ||
| Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source | Q34017348 | ||
| Interleukin-6 and d-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection | Q34142791 | ||
| Veterans Aging Cohort Study (VACS): Overview and description | Q34629666 | ||
| Plasma levels of soluble CD14 independently predict mortality in HIV infection | Q34764002 | ||
| Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. | Q34775968 | ||
| Is hypertension a prothrombotic state? | Q36137501 | ||
| Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy | Q36541079 | ||
| HIV infection and the risk of diabetes mellitus. | Q37365031 | ||
| Association of C-reactive protein and HIV infection with acute myocardial infarction | Q37390630 | ||
| Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. | Q37456616 | ||
| Leaky gut and diabetes mellitus: what is the link? | Q37850489 | ||
| Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study | Q40821822 | ||
| Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. | Q42970792 | ||
| Goodpasture syndrome during the course of a Schönlein-Henoch purpura. | Q43973121 | ||
| C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. | Q44701021 | ||
| Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans | Q45332965 | ||
| C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. | Q46005836 | ||
| Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. | Q50715480 | ||
| C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease | Q57605886 | ||
| Blood pressure and inflammation in apparently healthy men | Q74537835 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| HIV | Q15787 | ||
| inflammation | Q101991 | ||
| P304 | page(s) | 126-136 | |
| P577 | publication date | 2012-04-24 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation | |
| P478 | volume | 55 |
| Q64240956 | A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing? |
| Q37196037 | A review of cardiovascular and renal function monitoring: a consideration of older adults with HIV. |
| Q40051462 | Addressing Antiretroviral Therapy-Associated Drug-Drug Interactions in Patients Requiring Treatment for Opportunistic Infections in Low-Income and Resource-Limited Settings. |
| Q47204696 | Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation. |
| Q34094201 | Aging of the human innate immune system in HIV infection |
| Q30244921 | Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions |
| Q47588185 | Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected |
| Q40146631 | Association Between CD4(+), Viral Load, and Pulmonary Function in HIV. |
| Q36249027 | Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review |
| Q92772559 | Association between alcohol use and inflammatory biomarkers over time among younger adults with HIV-The Russia ARCH Observational Study |
| Q36330047 | Associations of Circulating Soluble Tumor Necrosis Factor-α Receptors 1 and 2 with Interleukin-6 Levels in an Aging Cohort of Injection Drug Users with or at High Risk for HIV Infection |
| Q30248286 | Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy |
| Q36775142 | Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy. |
| Q38883323 | Bronchiectasis and other chronic lung diseases in adolescents living with HIV. |
| Q37661603 | Cardiovascular disease and HIV infection |
| Q35064091 | Cardiovascular disease risk in an aging HIV population: not just a question of biology. |
| Q55012055 | Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viremia. |
| Q50138604 | Changes in inflammation but not in T cell activation precede non-AIDS-defining events in a case-control study of patients on long-term antiretroviral therapy |
| Q34342368 | Chronic HIV disease and activation of the coagulation system |
| Q40523298 | Cigarette Smoking and Inflammation, Monocyte Activation, and Coagulation in HIV-Infected Individuals Receiving Antiretroviral Therapy, Compared With Uninfected Individuals |
| Q40512776 | Cross sectional study of comorbidities and concomitant medications in a cohort of human immunodeficiency virus-infected patients |
| Q41757466 | Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study |
| Q35992200 | D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events |
| Q34784280 | Decreases in Inflammatory and Coagulation Biomarkers Levels in HIV-Infected Patients Switching from Enfuvirtide to Raltegravir: ANRS 138 Substudy |
| Q40422576 | Deep Vein Thrombosis as Initial Manifestation of Whipple Disease |
| Q92695624 | Depression and all-cause mortality risk in HIV-infected and HIV-uninfected US veterans: a cohort study |
| Q43135958 | Differential Relationships among Circulating Inflammatory and Immune Activation Biomediators and Impact of Aging and Human Immunodeficiency Virus Infection in a Cohort of Injection Drug Users |
| Q100395069 | Distinct lung microbiota associate with HIV-associated chronic lung disease in children |
| Q36901589 | Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? |
| Q98226280 | Effects of Internet Cognitive-Behavioral Therapy on Depressive Symptoms and Surrogates of Cardiovascular Risk in Human Immunodeficiency Virus: A Pilot, Randomized, Controlled Trial |
| Q35862321 | Elevated Biomarkers of Inflammation and Coagulation in Patients with HIV Are Associated with Higher Framingham and VACS Risk Index Scores |
| Q35219570 | Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohort |
| Q36220304 | Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in Persons Living With HIV. |
| Q33610887 | Emphysema is associated with thoracic vertebral bone attenuation on chest CT scan in HIV-infected individuals. |
| Q89593995 | Endothelial Activation, Innate Immune Activation, and Inflammation Are Associated With Postbronchodilator Airflow Limitation and Obstruction Among Adolescents Living With HIV |
| Q35338096 | Epidemiology and management of antiretroviral-associated cardiovascular disease |
| Q38966900 | Erectile Dysfunction, Testosterone Deficiency, and Risk of Coronary Heart Disease in a Cohort of Men Living with HIV in Belgium |
| Q34796197 | Evaluating the impact of sequencing depth on transcriptome profiling in human adipose |
| Q40075058 | Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns |
| Q36139186 | Factors Associated With Plasma IL-6 Levels During HIV Infection |
| Q35120065 | Factors associated with D-dimer levels in HIV-infected individuals |
| Q89135631 | Gut Microbial-Related Choline Metabolite Trimethylamine-N-Oxide Is Associated With Progression of Carotid Artery Atherosclerosis in HIV Infection |
| Q37683137 | HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation. |
| Q60946881 | HIV Proteins and Endothelial Dysfunction: Implications in Cardiovascular Disease |
| Q46042029 | HIV and Age Do Not Synergistically Affect Age-Related T cell Markers |
| Q38659387 | HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer |
| Q27016011 | HIV and aging: emerging research issues |
| Q38413754 | HIV infection : chronic disease with comorbidities |
| Q27008915 | HIV infection and cardiovascular disease |
| Q37354530 | HIV infection is associated with reduced pulmonary diffusing capacity |
| Q40372167 | HIV infection, ACS, PCI and high platelet reactivity: ingredients for a perfect thrombotic storm |
| Q27004165 | HIV infection, aging, and immune function: implications for cancer risk and prevention |
| Q40351539 | HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication |
| Q27015965 | HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities |
| Q56960000 | High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid |
| Q38683965 | High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC. |
| Q40374706 | Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults |
| Q35661912 | Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection |
| Q31127335 | Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study |
| Q36556082 | Immune activation and cardiovascular disease in chronic HIV infection |
| Q38711879 | Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls. |
| Q35041831 | Immune activation, HIV persistence, and the cure. |
| Q30593046 | Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort |
| Q58388931 | Immunological nonresponse to antiretroviral drugs in HIV infection |
| Q28080948 | Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat |
| Q34609920 | Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. |
| Q41454338 | Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity |
| Q37195784 | Infectious and Non-infectious Etiologies of Cardiovascular Disease in Human Immunodeficiency Virus Infection |
| Q58557904 | Inflammation Relates to Poorer Complex Motor Performance among Adults Living with HIV on Suppressive Antiretroviral Therapy |
| Q33926735 | Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems. |
| Q34229695 | Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease |
| Q26851535 | Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus |
| Q37262786 | Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation |
| Q38583848 | Interaction of obesity and infections |
| Q33792651 | Is HIV a model of accelerated or accentuated aging? |
| Q35860942 | Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities |
| Q39375437 | Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study. |
| Q26863389 | Lung function abnormalities in HIV-infected adults and children |
| Q35558823 | Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions |
| Q27024262 | Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients |
| Q33792101 | Microvascular Endothelial Dysfunction and Enhanced Thromboxane and Endothelial Contractility in Patients with HIV. |
| Q36991666 | Monocyte/macrophages and their role in HIV neuropathogenesis |
| Q35108968 | Monocytes expand with immune dysregulation and is associated with insulin resistance in older individuals with chronic HIV. |
| Q94568878 | Noninfectious Comorbidity in the African Cohort Study |
| Q37102014 | Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons |
| Q39959705 | Ouabain affects the expression of activation markers, cytokine production, and endocytosis of human monocytes |
| Q92529029 | Patho-immune Mechanisms of Hypertension in HIV: a Systematic and Thematic Review |
| Q40507828 | Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection |
| Q40632660 | Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals |
| Q47693953 | Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy. |
| Q36794209 | Race and gender variation in response to evoked inflammation |
| Q47190713 | Racial Comparison of D-dimer Levels in U.S. Male Military Personnel Before and After HIV Infection and Viral Suppression |
| Q44018745 | Rate and Predictors of Carotid Artery Intima Media Thickness Progression in Antiretroviral-Naive HIV-Infected and Uninfected Adults: A 48-Week Matched Prospective Cohort Study |
| Q37433961 | Relationship between poor physical function, inflammatory markers, and comorbidities in HIV-infected women on antiretroviral therapy |
| Q35493901 | Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort |
| Q40833745 | Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients. |
| Q90294828 | Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders |
| Q40751471 | Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial. |
| Q38749963 | Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection |
| Q37418140 | Serious Non-AIDS events: Immunopathogenesis and interventional strategies |
| Q64053467 | Severe infection increases cardiovascular risk among HIV-infected individuals |
| Q35996619 | Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study |
| Q34315579 | Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment |
| Q38985926 | Strategies to limit immune-activation in HIV patients. |
| Q33577551 | Systemic effects of inflammation on health during chronic HIV infection |
| Q35030351 | The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals |
| Q40047379 | The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol. |
| Q58747834 | The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort |
| Q47610317 | The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis |
| Q28300749 | The end of AIDS: HIV infection as a chronic disease |
| Q41891762 | The influence of Ouabain on human dendritic cells maturation |
| Q37025385 | The next therapeutic challenge in HIV: polypharmacy |
| Q36120745 | The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study |
| Q59793322 | The systematic development of a complex intervention: HealthMap, an online self-management support program for people with HIV |
| Q34430248 | Tumor necrosis factor α is associated with viral control and early disease progression in patients with HIV type 1 infection |
| Q57023614 | Using DNA methylation to validate an electronic medical record phenotype for smoking |
| Q38906902 | Validating Harmful Alcohol Use as a Phenotype for Genetic Discovery Using Phosphatidylethanol and a Polymorphism in ADH1B. |
| Q36404711 | Vitamin D status in Well-Controlled Caucasian HIV Patients in Relation to Inflammatory and Metabolic Markers--A Cross-Sectional Cohort Study in Sweden |
| Q31117473 | X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process |
Search more.